bilateral simultaneous endoscopic thoracic symapthectomy
ProcedurePatients underwent bilateral simultaneous T2-T3 ganglionectomy using thoracoscopic approach.
NCT Number: NCT02321332
Comparison between unilateral sequential and bilateral simultaneous endoscopic thoracic sympathectomy for palmar hyperhidrosis on patients outcomes notably compensatory hyperhidrosis.
Looking for future studies?
Notify Me8 year–50 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients underwent bilateral simultaneous T2-T3 ganglionectomy using thoracoscopic approach.
Patients underwent unilateral T2-T3 ganglionectomy of the dominant side followed by T2-T3 ganglionectomy of the other side after 2 months interval.
Time frame: one year
Number pf patients developing compensatory hyperhidrosis (reflex sweating) following sympathectomy. Compensatory hyperhidrosis was graded as "severe" when the patient mentioned that sweating interfered with his or her normal activity, "moderate" when the patient indicated that his or her sweating was not bothersome and "mild" when the patient did not mention dampness or made only a brief reference.
Time frame: one year
we measure patient satisfaction regarding the procedure by asking the patients to rate their level of satisfaction as very satisfied, somewhat satisfied, somewhat dissatisfied and very dissatisfied. Patients were considered satisfied if they reported being very satisfied or somewhat satisfied.
Tmaer Youssef Mohamed
Other
Unilateral Sequential Versus Bilateral Simultaneous Sympathectomy for Palmar Hyperhidrosis: a Study of 407 Cases.
Acronym: ETS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06731101
Palmar Hyperhidrosis
Al Fayyum, Egypt
View Trial DetailsNCT03880266
Palmar Hyperhidrosis
Encinitas, California, United States
View Trial DetailsNCT04906655
Hyperhidrosis, Palmar Hyperhidrosis
Norfolk, Virginia, United States
View Trial DetailsNCT03404570
Palmar Hyperhidrosis
San Diego, California, United States
View Trial Details